(06S93-21) On-a-call-as-needed basis from 7/1/2026 to 6/30/2027; ABBOTT ALINITY ANTI-HAV lgG reagent… and 6 more items

The Florida Department of Health awarded contract C77BA5 for the supply of Abbott Alinity diagnostic reagents on an as-needed basis. The contract, valued at $74,739.00, was executed on July 1, 2026, with a performance period extending through June 30, 2027. The contract encompasses seven distinct line items for hepatitis and syphilis testing reagents, including Abbott Alinity Anti-Hepatitis A Virus Immunoglobulin G reagent, Anti-Hepatitis B Core Antibody reagent, Anti-Hepatitis C Virus Antibody reagent, Anti-Hepatitis B Surface Antibody reagent, Hepatitis B Surface Antigen qualitative confirmatory test reagent, Hepatitis B Surface Antigen qualitative reagent, and Syphilis Treponemal immunoassay reagent.

The contract specifies quantities ranging from 3 to 22 kits across the seven line items, with each kit containing 200 tests. Unit prices per kit vary based on the specific reagent, ranging from $440.00 to $3,289.40, reflecting differences in per-test costs. The reagents are procured on a call-as-needed basis throughout the contract period, enabling the Department of Health to maintain adequate inventory for infectious disease screening and diagnostic testing operations. The contract completion date of September 23, 2026, likely represents an anticipated final delivery or administrative closure date prior to the contract's June 30, 2027 expiration.